AGO	Argonaute;
AKT	Protein kinase B;
AUC	Area Under Curve;
BCL2L2	Bcl-2-like protein 2;
BIN1	Bridging integrator 1 Protein;
BMI-1	B lymphoma Mo-MLV insertion region 1 homolog;
CAF	Cancer-associated fibroblast;
CCNG	Cyclin G;
CDDP	Cisplatin;
CDH1	Cadherin 1;
CDKN	Cyclin-dependent protein kinases;
COL10A1	Collagen Type X Alpha 1 Chain;
COL1A1	Collagen type 1 alpha 1;
CX3CL1	Chemokine ligand 1;
CXCL17	Chemokine (C-C motif) ligand 17 (CCL17);
CYP3A5	Cytochrome P450 family 3 subfamily A member 5;
DDR1	Discoidin Domain Receptor 1;
DFS	Disease-free survival;
DGCR8	DiGeorge syndrome chromosomal (or critical) region 8;
DNA	Deoxyribonucleic Acid;
EMT	Epithelial-to-Mesenchymal Transition;
FAP	Familial adenomatous polyposis;
FGF2	Fibroblast growth factor 2;
FGFR	Fibroblast growth factor;
FGFR2	Fibroblast growth factor receptor 2;
FOXP4	Forkhead box P4;
GLUT1	Glucose Transporter 1;
GRAP	GRB2 related adaptor protein;
GTP	Guanosine triphosphate;
HDAC	Histone deacetylase;
HNSCC	Head and neck squamous carcinoma;
HOXA10	Homeobox A10;
HOXB7	Homeobox B7;
HPV	Human papillomavirus;
ICAM	Intercellular adhesion molecule;
IGF	Insulin-like growth factor;
IL32	Interleukin 32;
ITGB1	Integrin subunit beta 1;
LATS2	Large tumor suppressor, homolog 2;
LIMK1	LIM Domain Kinase 1;
MEG3	Maternally expressed gene 3;
miRISC	miRNA induced silencing complex;
miRNAs	MicroRNAs;
MMP2	Matrix metalloproteinase-2;
mRNA	Messenger RNA;
MTMR3	Myotubularin related protein 3;
OSCC	Oral Squamous Cell Carcinoma;
PCNA	Proliferating cell nuclear antigen;
PDCD	Pyruvate dehydrogenase complex deficiency;
PTEN	Phosphatase and tensin homolog;
RASSF5	Ras Association Domain Family Member 5;
RB1	Retinoblastoma susceptibility gene;
RISC	RNA-induced silencing complex;
RNA	Ribonucleic acid;
ROC	Receiver operating characteristic;
SCAI	Suppressor of cancer cell invasion;
SCC	Squamous cell carcinoma;
SEMA6A	Semaphorin 6A;
SHP2	SH2 containing protein tyrosine phosphatase-2;
SOCS1	Suppressor of cytokine signaling 1;
STAT	Signal transducer and activator of transcription;
TIMP	Tissue inhibitor of metalloproteinase;
TME	Tumor microenvironment;
TNF-α	Tumor Necrosis Factor-α;
TRIAP1	TP53 regulated inhibitor of apoptosis 1;
TS-miRs	Tumor suppressor micro RNAs;
UCA1	Urothelial cancer-associated 1;
UTR	Untranslated regions;
YAP1	Yes-associated protein-1;
ZEB1	Zinc finger E-box binding homeobox;
SCAI	Suppressor of cancer cell invasion;
FGFR2	Fibroblast growth factor receptor 2;
FOXP4	Forkhead Box P4;
TRIAP1	TP53 Regulated Inhibitor of Apoptosis 1;
SIRT3	Sirtuin (silent mating type information regulation 2 homolog) 3;
IL32/AKT	AKT serine/threonine kinase 1;
CXCL17	Chemokine (C-C motif) ligand 17 (CCL17);
CDH1	Cadherin-1;
ARID2	AT-rich interactive domain-containing protein 2;
CD36	Cluster of differentiation 36;
CCNG2	Cyclin G2;
CYP3A5	Cytochrome P450 Family 3 Subfamily A Member 5;
SMAD7	Mothers against decapentaplegic homolog 7;
c-Myc	Cellular proto-oncogene;
ZEB1	Zinc Finger E-Box Binding Homeobox 1;
BIN1	Bridging Integrator-1;
SFRP1	Secreted frizzled-related protein 1;
IL6R	Interleukin 6 receptor;
HOXA10	Homeobox protein Hox-A10;
HDAC9	Histone Deacetylase 9;
MTDH	Metadherin;
CDK4/6	Cyclin-dependent kinase 4/6;
COL10A1	Collagen Type X Alpha 1 Chain;
TCTP	Translationally-controlled tumor protein;
YAP1	Yes-associated protein 1;
IKKβ	Inhibitor of nuclear factor kappa-B kinase subunit beta;
MMP2	Matrix Metallopeptidase 2;
MET	Proto-Oncogene, Receptor Tyrosine Kinase
SOX4	SRY-Box Transcription Factor 4;
LIMK1	LIM Domain Kinase 1;
TRIM14	Tripartite motif-containing protein 14;
GRAP	GRB2 Related Adaptor Protein;
TIMP3	Tissue inhibitor of metalloproteinase 3;
COL17	Collagen Type XVII Alpha 1 Chain;
SIX1	Sine oculis homeobox homolog 1;
VEGF-A	Vascular endothelial growth factor A;
STAT3	Signal transducer and activator of transcription 3;
EIF4B	Eukaryotic Translation Initiation Factor 4B;
RASSF5	Ras Association Domain Family Member 5;
CD44	Cluster of differentiation 44;
BMI-1	B lymphoma Mo-MLV insertion region 1 homolog;
CHD9	Chromodomain Helicase DNA Binding Protein 9;
WRN	Werner syndrome RecQ like helicase;
PPP2R5A	Protein phosphatase 2 regulatory subunit B alpha;
CXCL12	C-X-C Motif Chemokine Ligand 12;
AXIN2	Axis inhibition protein 2;
UBE2B	Ubiquitin-conjugating enzyme E2 B;
GFI1	Growth Factor Independent 1;
MTMR3	Myotubularin-related protein 3;
TRAF6	TNF Receptor Associated Factor 6;
SOCS3	Suppressor of Cytokine Signaling 3;
STAT3	Signal Transducer and activator of transcription 3;
DDR1	Discoidin Domain Receptor 1;
PDCD7	Programmed Cell Death 7;
HK2	Hexokinase 2;
TMEM182	Transmembrane Protein 182;
SEMA6A	Semaphorin 6A;
RhoA	Ras Homolog A;
IL24	Interleukin 24;
CCL4	C-C Motif Chemokine Ligand 4;
TIMP2	Tissue inhibitor of metalloproteinase 2;
TRIM14	Tripartite Motif Containing Protein 14;
WNT10B	Wingless-type MMTV integration site family, member 10B;
YES1	YES Proto-Oncogene 1;
CD44-ROCK	Rho Assisted Protein Kinase;
CAMK2N1	Calcium/Calmodulin Dependent Protein Kinase 2 Inhibitor 1;
OSM	Oncostatin M;
RALBP1	RalA binding protein 1;
COL1A1	collagen type 1 alpha 1;
LATS2	Large tumor suppressor kinase 2;
MCL1	Induced Myeloid leukemia cell differentiation protein;
TCF12	Transcription Factor 12;
NLRP3	NLR Family Pyrin Domain Containing 3;
AKT3	AKT Serine/Threonine Kinase 3;
BCL2L2	BCL2 Like protein 2;
IGF-1R	Insulin Like Growth Factor 1 Receptor;
CXCR4	C-X-C Chemokine receptor 4;
HOXB7	Homeobox B7;
PTPN11	Tyrosine-Protein phosphatase non-receptor type 11;
DKK1	Dickkopf WNT signaling pathway inhibitor 1;
LGALS3BP	Galectin 3 Binding Protein;
YAP1	Yes Associated Protein 1;
GIT1	G protein-coupled receptor kinase-interacting protein 1;
DENND2D	DENN Domain Containing 2D;
FBXW7	F-box/WD repeat-containing protein 7;
NOX4	NADPH Oxidase 4;
PRXL2A	Peroxiredoxin Like 2A;
SOX2	SRY-box 2;
NOTCH1	Notch homolog 1;
mTOR	Mechanistic target of rapamycin;
HOXA9	Homeobox A9;
NRP1	Neuropilin 1;
ITGβ8	Integrin β8;
SMAD2	Mothers against decapentaplegic homolog 2;
PDGF-A	Platelet derived Growth Factor Subunit A;
AGK	Acylglycerol Kinase;
SOCS2	Suppressor of Cytokine Signaling 2;
BARX2	Homeobox protein BarH-like 2;
CDC73	Cell Division Cycle 73;
ZEB1	Zinc Finger E-Box Binding Homeobox 1;
K-ras	Kirsten rat sarcoma viral oncogene homolog;
NLK	Nemo Like Kinase;
EZH2	Enhancer of Zeste Homolog 2;
PLD1	Phospholipase D1;
ICAM2	Intercellular Adhesion Molecule 2;
MCPH1	Microcephalin;
PUMA	p53 upregulated modulator of apoptosis;
SNAI2	Snail Family Transcriptional Repressor 2 (Slug)